• Home
  • Mutual Funds
  • Aditya Birla Sun Life Pharma & Healthcare Fund Growth

Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹1000

AUM (Fund size)

₹859 Cr

Lock In Period

N/A

Expense Ratio

2.3

Benchmark

BSE Healthcare Total Return

Exit Load

For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.

Summary

Latest details for Aditya Birla Sun Life Pharma & Healthcare Fund Growth include a ₹31.01 NAV as of Apr 24,2026 and returns since inception of 85.68%. Minimum investments start at SIP ₹100. The Aditya Birla Sun Life Pharma & Healthcare Fund Growth AUM is ₹859 Cr, with a lock-in of N/A years, expense ratio of 2.3%, and benchmark BSE Healthcare Total Return. Exit load is - For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.. In the growth review for 1M Month/Year, the fund recorded 5.09% returns, against a category average of 2.61% and a category best of 8.04%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M5.092.618.04
6M0.101.638.52
1Y3.915.518.78
3Y22.9117.61108.11

Portfolio Analysis

  • Equity: 97.62%
  • Debt: 2.35%
  • Others
As on: 2026-03-31
View allocation % by

1. Sun Pharmaceutical Industries Limited13.42%
2. Torrent Pharmaceuticals Limited5.03%
3. J.B. Chemicals & Pharmaceuticals Limited4.99%
4. Aurobindo Pharma Limited4.42%
5. Ajanta Pharmaceuticals Limited4.22%
6. Lupin Limited4.21%
7. IPCA Laboratories Limited4.11%
8. Abbott India Limited3.90%
9. Emcure Pharmaceuticals Ltd3.30%
10. Cipla Limited3.24%
11. Mankind Pharma Ltd2.93%
12. Shilpa Medicare Ltd2.26%
13. Alkem Laboratories Limited2.16%
14. CORONA Remedies Ltd2.12%
15. SAI Life Sciences Ltd2.09%
16. Procter & Gamble Health Limited1.97%
17. Divi's Laboratories Limited1.80%
18. Dr. Reddys Laboratories Limited1.45%
19. Pfizer Limited1.40%
20. ALEMBIC PHARMACEUTICALS LIMITED1.24%
21. Biocon Limited1.14%
22. Jubilant Pharmova Ltd1.11%
23. ANTHEM BIOSCIENCES LIMITED1.08%
24. Gland Pharma Limited0.99%
25. Piramal Pharma Ltd0.92%
26. GlaxoSmithKline Pharmaceuticals Limited0.87%

1. Apollo Hospitals Enterprise Limited7.34%
2. Fortis Healthcare Limited3.49%
3. Jupiter Life Line Hospitals Ltd1.96%
4. Thyrocare Technologies Limited1.44%
5. METROPOLIS HEALTHCARE LIMITED1.36%
6. Suraksha Diagnostic Ltd0.89%
7. Vijaya Diagnostic Centre Limited0.78%
8. Max Healthcare Institute Limited0.78%

1. SANOFI CONSUMER HEALTHCARE1.58%

About Fund

Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹859 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.3. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Dhaval Shah

Mr. Dhaval Shah holds B.Com, CFA, MMS - Finance (Post graduation). He has worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
This FundTata India Pharma & HealthCare Fund Growth21229.42 CR2.15
This FundNippon India Pharma Fund Growth47898.24 CR1.82
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth2858.87 CR2.3
This FundUTI Healthcare Fund Growth31055.53 CR2.28
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth56293.14 CR1.87
Fund Name1Y3Y
This FundTata India Pharma & HealthCare Fund Growth0.63781.0709
This FundNippon India Pharma Fund Growth2.771182.1575
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth3.907385.6805
This FundUTI Healthcare Fund Growth5.390893.2855
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth4.5249102.8409

FAQs

Aditya Birla Sun Life Pharma & Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is 2.3. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 5.09%
  • 6 Months : 0.10%
  • 1 Year : 3.91%
  • 3 Years : 22.91%
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Growth are updated daily based on NAV of ₹ 31.01 as on Apr 24,2026. Since inception, the return has been 85.68%.

You can invest in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹859 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500